EUVIMED · CrossrefJournal
Cardiovascular Diabetology
ISSN 1475-2840 · Springer Science and Business Media LLC
Latest articles
Epicardial adipose tissue imaging as a cardiometabolic biomarker in diabetes: from pathophysiology to clinical translation
Prediagnostic plasma proteomic patterns and protein signature for incident peripheral artery disease in type 2 diabetes
Diabetes mellitus and 10-year clinical outcomes after percutaneous coronary intervention with drug-eluting stents: insights from the DECADE cooperation
OTUD5 protects against diabetic cardiomyopathy by preventing cardiomyocyte apoptosis through deubiquitination and stabilization of FOXO3a
Associations of cumulative C-reactive protein–triglyceride glucose index and cumulative functional limitation burden with incident cardiovascular disease among individuals with stages 0–3 cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study
Diabetes-duration-related myocardial microstructural remodeling and diastolic dysfunction in type 2 diabetes with preserved ejection fraction: a cardiac diffusion tensor imaging study
Associations of composite metabolic indices with adverse outcomes in stage 0–3 cardiovascular-kidney-metabolic syndrome: a scoping review and evidence map
Distinct trajectories of coronary artery disease in women with type 1 and type 2 diabetes: a narrative review
Exacerbating effect of glucose on phosphate-induced endothelial calcification: analysis of lipidome signature modification
Associations of baseline, cumulative, and longitudinal trajectories of the C-reactive protein–triglyceride-glucose index–frailty index composite (CTI-FI) with progression from cardiovascular-kidney-metabolic syndrome stages 0–2 to stages 3–4 or stage 4: a prospective cohort study from CHARLS
Associations of four triglyceride-related metabolic surrogate indices with heart rate variability and confirmed cardiovascular autonomic neuropathy in type 2 diabetes: a cross-sectional study
Estimated glucose disposal rate and lipoprotein(a) as complementary markers of cardiovascular risk in the UK Biobank
Biological age acceleration, plasma proteomics, and incident arrhythmias in type 2 diabetes
Cardiovascular disease risk prediction in type 1 diabetes over 30 years: the DCCT/EDIC Study
BMI-discrepant phenotypes and transitions reveal sex-specific heterogeneity and reshape cardiometabolic risk in Chinese adults
Exercise intensity-dependent metabolic signatures and cardiovascular protection in type 2 diabetes: evidence from NMR metabolomics in the UK Biobank
Stress-hyperglycemia ratio, frailty index, and their product in relation to incident cardiometabolic multimorbidity comprising diabetes, heart disease, and stroke: a longitudinal analysis of CHARLS
Associations of baseline levels, cumulative exposure, and two-wave patterns of the combined triglyceride-glucose index and frailty index with progression from cardiovascular-kidney-metabolic syndrome stages 0–2 to stages 3–4 and stage 4: a prospective cohort study from CHARLS
CORAL: a machine learning algorithm to identify coronary microvascular disease from doppler coronary blood flow patterns
Associations of cumulative exposure and dynamic trajectories of the combined estimated glucose disposal rate and frailty index with incident cardiometabolic multimorbidity comprising diabetes, heart disease, and stroke: a longitudinal analysis based on the China health and retirement longitudinal study (CHARLS)
Cumulative estimated glucose disposal rate and longitudinal eGDR patterns in relation to incident cardiovascular disease among middle-aged and older adults with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
Joint association of five insulin resistance indices and frailty index with incident cardiometabolic multimorbidity in individuals with cardiovascular–kidney–metabolic syndrome stages 0–3: a prospective cohort study
Evaluative performance of triglyceride-glucose-frailty index versus surrogate insulin resistance indices for advanced cardiovascular-kidney-metabolic syndrome, cardiometabolic multimorbidity, and mortality: the role of estimated glomerular filtration rate
Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study
Excess risk of cardiovascular disease and mortality after amputation in type 2 diabetes: a nationwide population study from the Swedish National Diabetes Register
Fatty liver index-defined hepatic steatosis and impaired fasting glucose differentially associate with incident diabetes and cardiovascular events in older adults: a nationwide cohort study
Joint effects of phenotypic age acceleration and novel insulin resistance indicators on mortality in adults with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
Endpoint-specific associations of the cholesterol, high-density lipoprotein, and glucose (CHG) index and its adiposity- and inflammation-related derivatives with incident cardiovascular disease and mortality: evidence from CHARLS and NHANES
Association of the cholesterol, high-density lipoprotein, and glucose (CHG) index with mortality after acute myocardial infarction: evidence from two large prospective cohorts
Correction: Associations of cumulative exposure and dynamic trajectories of the triglyceride-total cholesterol-body weight index with new-onset cardiometabolic multimorbidity in middle-aged and older Chinese adults: evidence from a nationwide prospective cohort study
EUVIMED